Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Influenza vaccines

H D Brede1

  • 1Chemotherapeutisches Forschungsinstitut, Frankfurt, Germany.

International Archives of Allergy and Immunology
|December 1, 1995
PubMed
Summary
This summary is machine-generated.

This report discusses influenza vaccines for the 1995/1996 season. While inactivated vaccines are licensed, experimental live vaccines are being evaluated for high-risk individuals, as current options offer incomplete protection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Large proportion of non-B HIV-1 subtypes and presence of zidovudine resistance mutations among German seroconvertors.

AIDS (London, England)·1997
Same author

[Aids].

Pharmazie in unserer Zeit·1997
Same author

Viral safety of a new highly purified factor VIII (OCTATE).

Journal of medical virology·1996
Same author

Influenza surveillance: experiences from establishing a sentinel surveillance system in Germany.

Journal of epidemiology and community health·1995
Same author

High proportion of HIV-2 and HIV-1/2 double-reactive sera in two Indian states, Maharashtra and Goa: first appearance of an HIV-2 epidemic along with an HIV-1 epidemic outside of Africa.

Zentralblatt fur Bakteriologie : international journal of medical microbiology·1994
Same author

HIV-1 and HIV-2 infections in a high-risk population in Bombay, India: evidence for the spread of HIV-2 and presence of a divergent HIV-1 subtype.

Journal of acquired immune deficiency syndromes·1992
Same journal

Differences in Reported Anaphylaxis Associated With Common Nonsteroidal Anti-inflammatory Drugs: A Pharmacovigilance Study.

International archives of allergy and immunology·2026
Same journal

Association of Serum Galectin-3 Binding Protein with Acute Exacerbation, Inflammation, and Airway Remodeling in Pediatric Asthma.

International archives of allergy and immunology·2026
Same journal

Effectiveness of a Provincial Law to Improve Epinephrine Use for Anaphylaxis in Schools in Alberta, Canada: A Pre-Post Study.

International archives of allergy and immunology·2026
Same journal

Rab27 a regulates dendritic cell immune tolerogenic capacity.

International archives of allergy and immunology·2026
Same journal

Burden of Hereditary Angioedema in Adults: Impact of Disease and Patient Characteristics.

International archives of allergy and immunology·2026
Same journal

Predictors of Treatment Response to Omalizumab in Children with Chronic Spontaneous Urticaria: A Real World Study.

International archives of allergy and immunology·2026
See all related articles

Area of Science:

  • Immunology
  • Vaccinology
  • Public Health

Background:

  • Influenza poses a significant public health risk, particularly for high-risk populations.
  • Vaccination is a primary strategy for influenza prevention.
  • Existing influenza vaccines have limitations in providing complete protection.

Purpose of the Study:

  • To review recommendations for 1995/1996 influenza vaccine components.
  • To discuss the types of influenza vaccines available and under development.
  • To evaluate the potential of experimental live influenza vaccines for immunoprophylaxis.

Main Methods:

  • Review of recommendations for influenza vaccine composition.
  • Analysis of licensed inactivated influenza vaccines for parenteral administration.

Related Experiment Videos

  • Evaluation of experimental live influenza vaccines for efficacy in high-risk groups.

    • Main Results:

    • Specific influenza vaccine components for the 1995/1996 season are cited.
    • Inactivated influenza vaccines are the only type licensed for human parenteral use.
    • Experimental live influenza vaccines show potential for immunoprophylaxis in high-risk individuals.

    Conclusions:

    • Current inactivated influenza vaccines do not offer complete protection against influenza.
    • Live influenza vaccines are being explored as an alternative or supplement for high-risk populations.
    • Further research and development of influenza vaccines are necessary to improve protection.